Virtu Financial’s MediciNova MNOV Stock Holding History

Virtu Financial’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-25,674	Closed	-$53K	–	1855
2022 Q4	$53K	Buy	+25,674	New	+$56.7K	0.01%	1071
2021 Q1	–	Sell	-16,725	Closed	-$88K	–	1863
2020 Q4	$88K	Buy	+16,725	New	+$95.8K	0.01%	1097

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu Financial's MNOV Position: Q1 2023 in Review

Virtu Financial sold out of MediciNova (MNOV) in Q1 2023, closing a stake of 25,674 shares — an estimated $53K sold.

Virtu Financial first reported a position in MNOV in Q4 2020 and held it in 2 quarters. The position peaked at $88K in Q4 2020. 40 funds tracked by Wall St. Rank hold MNOV as of Q1 2023.

Virtu Financial reported no remaining MediciNova position as of Q1 2023 after selling out during the quarter.
Virtu Financial sold 25,674 MediciNova shares in Q1 2023, an estimated $53K.
Virtu Financial first reported a position in MediciNova in Q4 2020 and held it in 2 quarters.
Virtu Financial's MediciNova position peaked at $88K in Q4 2020.
40 funds tracked by Wall St. Rank held MediciNova as of Q1 2023.

Based on Virtu Financial's 13F filing for Q1 2023, filed 1 May 2023.